M/S Indian Medicines Pharmaceutical Corporation Limited (impcl) v. Kerala Ayurvedic Co Operative Society Ltd.

Court

Supreme Court of India

Decided

3 January 2023

Case no.

C.A. No.-006693-006693 - 2022

Bench

The Chief Justice, Pamidighantam Sri Narasimha

Author

The Chief Justice

Facts

The Kerala Ayurvedic Cooperative Society filed a petition before the Lucknow Bench of the High Court of Judicature at Allahabad under Article 226 of the Constitution, challenging an order from the State of Uttar Pradesh that favored IMPCL for the purchase of Ayurvedic medicines. The High Court ruled in favor of the Society on October 18, 2019, directing the State to adopt a transparent process for procurement. Subsequently, both the State and IMPCL appealed to the Supreme Court under Article 136 of the Constitution. The case revolves around the interpretation of Paragraph 4(vi)(b) of the Operational Guidelines of NAM, which governs the procurement of Ayurvedic medicines.

Arguments

Petitioner Arguments

The petitioner, Kerala Ayurvedic Cooperative Society, argued that the State's decision to procure medicines exclusively from IMPCL violated the principles of transparency and fairness mandated by the Operational Guidelines of NAM. They contended that the guidelines required a tender process to ensure competitive pricing and quality. The court addressed these arguments by emphasizing the necessity of a transparent procurement process, thereby validating the petitioner's concerns about the lack of competition and potential misuse of power.

Respondent Arguments

The respondents, including the State of Uttar Pradesh and IMPCL, argued that the Operational Guidelines allowed for direct procurement from IMPCL without the need for a tender process, as long as a certain percentage of the grant-in-aid was allocated to IMPCL. They claimed that this provision was designed to support public sector undertakings. The court countered this argument by interpreting the guidelines in a manner that underscored the importance of competitive bidding, thereby rejecting the notion that the guidelines permitted bypassing the tender process.

Precedents considered

The judgment did not explicitly cite prior case law but relied on established legal principles regarding government procurement and the necessity of transparency and fairness in public contracts. The court's reasoning was grounded in constitutional principles that govern administrative actions and the need for accountability in the use of public funds.

Legal principles

The court considered several legal principles, including

• The necessity of a transparent and competitive bidding process in government contracts.
• The interpretation of operational guidelines in the context of public procurement.
• The balance between supporting public sector undertakings and ensuring fair competition.

Decision and reasoning

Rationale

The court's rationale centered on the interpretation of the Operational Guidelines of NAM, particularly Paragraph 4(vi)(b). It concluded that while the guidelines allowed for a certain percentage of procurement from IMPCL, they did not exempt the State from the obligation to invite tenders. The court criticized the conflation of power and duty, emphasizing that the State must act in accordance with principles of fairness and transparency.

Outcome

The Supreme Court upheld the High Court's decision, ordering the State of Uttar Pradesh to conduct a transparent tender process for the procurement of Ayurvedic medicines. The court did not specify conditions for bail or timelines for the appeal process, as the focus was on ensuring compliance with procurement guidelines.

Conclusion

This judgment reinforces the importance of transparency and competitive bidding in government procurement processes. It highlights the judiciary's role in ensuring that public authorities adhere to established guidelines, thereby promoting accountability and fairness in the use of public resources.

Read the full judgment on the Supreme Court website (PDF)